May 24, 2016
The Ministry of Health, Labor and Welfare (MHLW) approved four drugs for additional indications on May 23, including Chugai Pharmaceutical’s Avastin (bevacizumab) for the treatment of advanced or recurrent cervical cancer. Here is the list of drugs approved on the...read more